John Hester
Stock Analyst at Bell Potter
(4.05)
# 1,703
Out of 5,014 analysts
228
Total ratings
48.4%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: MSB Mesoblast Limited | Reiterated: Buy | $4.45 | $2.10 | +112.41% | 22 | Sep 27, 2026 | |
| ASX: EIQ Echo IQ Limited | Reiterated: Sell | $0.30 | $0.58 | -48.28% | 5 | Sep 22, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $19.00 | $15.56 | +22.11% | 35 | Sep 21, 2026 | |
| ASX: 4DX 4DMedical Limited | Reiterated: Buy | $6.00 | $4.24 | +41.51% | 14 | Aug 30, 2026 | |
| ASX: PNV PolyNovo Limited | Upgraded: Buy | $1.00 → $1.22 | $0.91 | +34.81% | 13 | Aug 28, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Upgraded: Buy | $3.00 | $2.57 | +16.73% | 6 | Aug 28, 2026 | |
| ASX: PGC Paragon Care Limited | Reiterated: Hold | $0.17 → $0.16 | $0.14 | +18.52% | 18 | Aug 27, 2026 | |
| ASX: NAN Nanosonics Limited | Reiterated: Hold | $3.60 → $3.20 | $2.91 | +9.97% | 17 | Aug 26, 2026 | |
| ASX: CYC Cyclopharm Limited | Reiterated: Buy | $1.00 | $0.46 | +119.78% | 15 | Aug 25, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Buy | $226.00 | $162.28 | +39.27% | 16 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.24 → $0.22 | $0.12 | +91.30% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13.00 | $11.18 | +16.28% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.50 → $6.40 | $2.14 | +199.77% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.45 → $0.42 | $0.25 | +71.43% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.09 | $0.50 | +118.00% | 7 | Jul 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.25 | $0.04 | +525.00% | 7 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.05 → $0.06 | $0.01 | +757.14% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.02 | n/a | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.01 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.94 → $3.90 | $4.28 | n/a | 3 | Nov 25, 2022 |
Mesoblast Limited
Sep 27, 2026
Reiterated: Buy
Price Target: $4.45
Current: $2.10
Upside: +112.41%
Echo IQ Limited
Sep 22, 2026
Reiterated: Sell
Price Target: $0.30
Current: $0.58
Upside: -48.28%
Telix Pharmaceuticals Limited
Sep 21, 2026
Reiterated: Buy
Price Target: $19.00
Current: $15.56
Upside: +22.11%
4DMedical Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $6.00
Current: $4.24
Upside: +41.51%
PolyNovo Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $1.00 → $1.22
Current: $0.91
Upside: +34.81%
Sigma Healthcare Limited
Aug 28, 2026
Upgraded: Buy
Price Target: $3.00
Current: $2.57
Upside: +16.73%
Paragon Care Limited
Aug 27, 2026
Reiterated: Hold
Price Target: $0.17 → $0.16
Current: $0.14
Upside: +18.52%
Nanosonics Limited
Aug 26, 2026
Reiterated: Hold
Price Target: $3.60 → $3.20
Current: $2.91
Upside: +9.97%
Cyclopharm Limited
Aug 25, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.46
Upside: +119.78%
Pro Medicus Limited
Aug 19, 2026
Reiterated: Buy
Price Target: $226.00
Current: $162.28
Upside: +39.27%
Aug 18, 2026
Reiterated: Buy
Price Target: $0.24 → $0.22
Current: $0.12
Upside: +91.30%
Aug 12, 2026
Downgraded: Hold
Price Target: $13.00
Current: $11.18
Upside: +16.28%
Aug 10, 2026
Reiterated: Buy
Price Target: $6.50 → $6.40
Current: $2.14
Upside: +199.77%
Aug 3, 2026
Reiterated: Buy
Price Target: $0.45 → $0.42
Current: $0.25
Upside: +71.43%
Jul 12, 2026
Reiterated: Buy
Price Target: $1.09
Current: $0.50
Upside: +118.00%
May 28, 2026
Reiterated: Buy
Price Target: $0.25
Current: $0.04
Upside: +525.00%
Dec 17, 2025
Reiterated: Buy
Price Target: $0.05 → $0.06
Current: $0.01
Upside: +757.14%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.02
Upside: n/a
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.01
Upside: n/a
Nov 25, 2022
Reiterated: Hold
Price Target: $4.94 → $3.90
Current: $4.28
Upside: n/a